Tobetsa mona ho bonts'a lifolakha tsa HAO leqepheng lena mme u lefelle katleho feela

Bonngoe

Polelo ea Mmaraka ea Kalafo ea Radioimmunotherapy e nang le Tšusumetso e Ka bang teng le Bokamoso ba Bokamoso, Fumana FMI 2022 - 2027

ngotsoeng ke mohlophisi

Kankere ke sesosa se ka sehloohong sa lefu lefatšeng ka bophara 'me ho hakanngoa hore e tla phahama ka batho ba hakanyetsoang ho ba limilione tse 11.5 ka 2030. Kankere e tloaelehileng ka ho fetisisa ke kankere ea matšoafo, e bakang batho ba ka bang limilione tse 1.59, mefuta e meng ea kankere e kenyelletsa kankere ea sebete, kankere ea matsoele, kankere ea mala, kankere ea sebete, joalo-joalo Kankere e ka phekoloa ka ho buuoa, chemotherapy, phekolo ea mahlaseli, phekolo ea hormone, phekolo e lebisitsoeng, meriana e nepahetseng, immunotherapy le stem cell transplantation. Immunotherapy e kenyelletsa tšebeliso ea sesole sa 'mele sa motho ho loantša mofetše; e kenyelletsa ho hlohlelletsa sesole sa 'mele ho hlasela lisele tsa mofetše kapa ho fana ka sesole sa 'mele ka sesole sa 'mele se entsoeng ke motho.

Mefuta e fapaneng ea immunotherapy e kenyelletsa li-antibodies tsa monoclonal, tse etselitsoeng ho hlasela lisele tse itseng; immune checkpoint inhibitors, lithethefatsi tse hlokomelang le ho hlasela lisele tsa mofetše ka ho tlosa mariki a T cell; Liente tsa mofets'e, tse sebelisetsoang ho tsosa karabelo ea 'mele ea ho itšireletsa mafung khahlano le mafu a itseng le tse ling tse fapaneng tse fapaneng tsa immunotherapy li sebelisoa ho matlafatsa sesole sa' mele. Radioimmunotherapy ke motsoako oa phekolo ea mahlaseli le immunotherapy. Monoclonal antibody e entsoe ka laboratoring 'me e kopantsoe le thepa ea radioactive e bitsoang radiotracers. Ha e entoa, seea-le-moea se ne se tšoaea antibody ho tlama seleng e itseng ea mofetše 'me sa senya sele ea mofetše ka radioactivity ea eona. Lisebelisoa tsa radioactive tse sebelisoang haholo-holo ke Yttrium-90 Ibritumomab Tiuxetan, Iodine-131 Tositumomab, le tse ling.

Ho lula u le 'ka pele' ho bahlolisani ba hau, kopa a bukana: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3701

Liteko tse 'maloa tsa bongaka li ntse li tsoela pele ho fumana bokhoni ba seea-le-moea se bitsoang monoclonal antibody. Radioimmunotherapy e boetse e sebelisoa ho alafa bakuli ba nang le non-Hodgkin B-cell lymphoma, le mefuta e meng e nyane ea lymphoma kapa bakuli ba sa arabeleng kalafo ea chemotherapy. Ka kakaretso, ha ho na litla-morao tse bonoang nakong ea phekolo. Lefapheng la bongaka, lithuto tsa bongaka li etsoa ho ntlafatsa katleho ea baeloji le lik'hemik'hale le ntlafatso ea ts'ebetso ea kalafo ho radioimmunotherapy. Mokhoa o tobileng le o sa tobang o sebelisoa phepelong ea limolek'hule tsa radioimmunotherapy. Keketseho ea lichelete tsa boikhethelo bakeng sa lipatlisiso tsa mofets'e ke mmuso le mekhatlo ea mmuso, keketseho ea ts'ireletso ea Medicare, ho ata ha mofets'e har'a batho ba ntseng ba eketseha, ho fumaneha ha kalafo e ncha ea mofetše, le lintlha tse ling tse fapaneng li tla matlafatsa 'maraka oa radioimmunotherapy haufinyane.

Mmaraka oa Kalafo ea Radioimmunotherapy: Bakhanni le Lithibelo

Ho latela Word Health Organization, ho hakanngoa hore ka 2030, ho tla be ho e-na le batho ba ka bang limilione tse 23.6 ba tšoeroeng ke kankere lefatšeng ka bophara. Litaelo tsa mmuso tse tsoang ho American Society of Clinical Oncology le National Comprehensive Cancer Network (NCCN / ASCO) li fana ka thuso ho litsebi tsa tlhokomelo ea bophelo tsamaisong le kalafo ea bakuli ba mofetše. Patlisiso e matla le nts'etsopele ea kalafo ea mofets'e, ho phahama ha liketsahalo tsa mofets'e, ho eketsa khetho ea lipatlisiso tsa mofetše. Ka Mmesa 2016, Mmuso wa Amerika o ile wa abela US$ 5.2 Bn bakeng sa Setsi sa Naha sa Kankere (NCI), e leng setsi sa mmuso oa kopanelo, bakeng sa lipatlisiso le koetliso ea mofetše. Tekanyetso e eketsehile ka 5.3% ha e bapisoa le ea selemo se fetileng. Litaba tsa inshorense le litefello, lik'hamphani tse kholo li tsetela haholo kalafong ea mofets'e e kenyelletsang nako le chelete, 'me ha ho na tiiso ea hore sehlahisoa se tla fumana tšireletso, kotsi ea radiation ho litsebi tsa bophelo bo botle le bakuli ke lintlha tse ling tse ka fokotsang kholo ea seea-le-moea. -'maraka oa immunotherapy

Mmaraka oa Kalafo ea Radioimmunotherapy: Kakaretso

E ipapisitse le mofuta oa lithethefatsi, lefats'e Mmaraka oa kalafo oa radioimmunotherapy e arotsoe ka ibritumomab, tositumomab, rituximab, epratuzumab, lintuzumab, labetuzumab le trastuzumab. Motheong oa mofuta oa ts'ebetso mmaraka oa kalafo oa radioimmunotherapy o arotsoe ka mokhoa o tobileng le o sa tobang. O Motheong oa sesupo sa lefu, 'maraka o arotsoe ka non-hodgkin lymphoma, myeloid leukemia, mofetše oa colorectal, mofetše oa matsoele, myeloma e mengata le tse ling. Ho ipapisitsoe le basebelisi ba ho qetela, 'maraka o arotsoe ka lipetlele, litsi tsa ho buoa ambulense le litsi tsa lipatlisiso tsa mofetše. Keketseho ea palo ea bakuli ba mofets'e, lithuso tsa lichelete ke mekhatlo ea mmuso, li shebane le ho nkuoa le ho kopanngoa ke baetsi ba bohlokoa ba fapaneng ho hlahisoa kholo ea 'maraka oa kalafo ea radio-immunotherapy.

Radioimmunotherapy Treatment Market: Tlhaloso ea Libaka

Ka bohlale, 'maraka oa lefats'e oa Radioimmunotherapy Treatment o arotsoe ka libaka e leng, Amerika Leboea, Latin America, Europe Bophirimela, Europe Bochabela, Asia-Pacific, Japan, Middle East le Afrika. Ho feta 70% ea lefu la mofetše lefatšeng le hlaha Afrika, Asia le Amerika Boroa. Hoo e ka bang 33% ea linyeoe tsa mofetše lefatšeng ka bophara li bakoa ke mosi le koae. Hammoho le katoloso ea mebaraka e ntseng e hola, le ho tsepamisa maikutlo ho hoholo ho hlahlojoeng, ho lekola, ho beha leihlo le nts'etsopele ea bongaka e amanang le kalafo ea radiotherapy e bile maano a maholo a amohetsoeng ke libapali tse kholo 'marakeng oa lefats'e oa kalafo oa radioimmunotherapy.

Mmaraka oa Kalafo ea Radioimmunotherapy: Libapali tsa Bohlokoa

Ba bang ba libapali tsa bohlokoa 'Marakeng oa Lefatše oa Kalafo ea Radioimmunotherapy ke GlaxoSmithKline plc. Bayer AG, MabVax Therapeutics Holdings, Inc., Panacea Pharmaceuticals, Inc. Nordic Nanovector, Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Spectrum Pharmaceuticals, Inc.le ba bang.

Tlaleho ea lipatlisiso e fana ka tlhahlobo e felletseng ea mmaraka mme e na le lintlha tse nahannoeng hantle, lintlha, lintlha tsa nalane, le lintlha tsa mmaraka tse tšehelitsoeng ka lipalo le tse netefalitsoeng ke indasteri. E boetse e na le likhakanyo tse sebelisang sete e nepahetseng ea mehopolo le mekhoa. Tlaleho ea lipatlisiso e fana ka tlhahlobo le tlhaiso-leseling ho latela mekhahlelo e joalo ka likarolo tsa 'maraka, libaka, mofuta oa sehlahisoa le lits'ebetso.

Tlaleho e akaretsa tlhahlobo e matla ho:

  • Likarolo tsa Mmaraka
  • Matlafatso a 'Maraka
  • Boholo ba Mmaraka
  • Phepelo le Tlhokahalo
  • Mekhoa ea morao-rao / Litaba / Liphephetso
  • Tlholisano le Likhamphani tse amehang
  • Technology
  • Chain ea boleng

Tlhahlobo ea tikoloho e kenyelletsa

  • Amerika Leboea (US, Canada)
  • Latin America (Mexico, Brazil le Latin America kaofela)
  • Europe Bophirimela (Jeremane, Italy, Fora, UK, Spain, linaha tsa Nordic, Belgium, Netherlands, Luxembourg le Europe Bophirima kaofela)
  • Europe Bochabela (Poland, Russia le Europe Bochabela)
  • Asia Pacific (China, India, ASEAN, Australia le New Zealand)
  • Japan
  • Botjhabela bo Hare le Afrika (GCC, S. Africa, le MEA kaofela)

Tlaleho ke pokello ea tlhahisoleseding ea pele, tlhahlobo ea boleng le palo e entsoeng ke bahlahlobisisi ba indasteri, maikutlo a tsoang ho litsebi tsa indasteri le bankakarolo ba indasteri ho pholletsa le ketane ea boleng. Tlaleho e fana ka tlhahlobo e tebileng ea mekhoa ea 'maraka oa batsoali, matšoao a moruo o moholo le lintlha tse laolang hammoho le ho hohela 'maraka ho latela likarolo. Tlaleho e boetse e fana ka 'mapa oa phello ea boleng ba lintlha tse fapaneng tsa mmaraka likarolong tsa mebaraka le libaka

Mmaraka oa Kalafo ea Radioimmunotherapy: Karohano

Mmaraka oa lefats'e oa kalafo ea radioimmunotherapy o arotsoe ho ipapisitsoe le mofuta oa lithethefatsi, mofuta oa ts'ebetso, sesupo sa lefu, mofuta oa sepheo le jeokrafi.

Ho ipapisitsoe le Mofuta oa Lithethefatsi, 'maraka oa kalafo oa radioimmunotherapy o arotsoe ka tse latelang:

  • Ibritumomab
  • Tositumomab
  • Rituximab
  • Epratuzumab
  • Lintuzumab
  • Labetuzumab
  • Trastuzumab
  • Ba bang ba

Ho ipapisitsoe le Mofuta oa Ts'ebetso, 'maraka oa lefats'e oa kalafo oa radioimmunotherapy o arotsoe ka tse latelang:

  • Mokhoa o tobileng
  • Mokhoa o sa tobang

Ho ipapisitsoe le Letšoao la Mafu, 'maraka oa lefats'e oa kalafo ea radioimmunotherapy o arotsoe ka tse latelang:

  • E seng Hodgkin lymphoma
  • Leukemia ea myeloid
  • Kankere e nepahetseng
  • Kankere ea matsoele
  • Myeloma e ngata
  • Ba bang ba

Ho ipapisitsoe le Mosebelisi, 'maraka oa lefats'e oa kalafo oa radioimmunotherapy o arotsoe ka tse latelang:

  • lipetlele
  • Litsi tsa ho buoa ambulatory
  • Mekhatlo ea Lipatlisiso tsa Kankere
  • Ba bang ba

Ho fetela pele, fumana TOC ea Tlaleho ena:  https://www.futuremarketinsights.com/toc/rep-gb-3701

Tlaleha Lintlha-khōlō:

  • Tlhaloso e qaqileng ea mmaraka oa motsoali
  • Ho fetola matla a 'maraka indastering
  • Karolo e tebileng ea 'maraka
  • Boholo ba 'maraka ba nalane, ea hajoale le e nahannoeng ho latela bophahamo le boleng
  • Mekhoa ea morao-rao ea indasteri le nts'etsopele
  • Sebaka sa tlhōlisano
  • Maano a libapali tsa bohlokoa le lihlahisoa tse fanoang
  • Likarolo tse ka bang teng le tse ntle, libaka tsa tikoloho tse bonts'ang kholo e ts'episang
  • Maikutlo a sa nke lehlakore mabapi le ts'ebetso ea 'maraka
  • E tlameha ho ba le tlhaiso-leseling bakeng sa libapali tsa mmaraka ho boloka le ho ntlafatsa mehato ea bona ea mmaraka

Mabapi le 'Maraka oa Bokamoso oa Limaraka (FMI)
Future Market Insights (FMI) ke mofani ea ka sehloohong oa lits'ebeletso tsa bohlale ba 'maraka le lits'ebeletso tsa boeletsi, e sebeletsang bareki linaheng tse fetang 150. FMI e ikarabella ho Dubai, 'me e na le litsi tsa liphallelo UK, US le India. Litlaleho tsa morao-rao tsa lipatlisiso tsa 'maraka tsa FMI le tlhahlobo ea indasteri li thusa likhoebo ho sebetsana le mathata le ho etsa liqeto tsa bohlokoa ka boits'epo le ho hlaka har'a tlholisano e mpe. Litlaleho tsa rona tsa liphuputso tsa 'maraka tse hlophisitsoeng le tse kopantsoeng li fana ka lintlha tse ka sebetsang tse tsamaisang kholo e tsitsitseng. Sehlopha sa bahlahlobisisi ba etelletsoeng pele ke litsebi ho FMI se lula se latela mekhoa le liketsahalo tse ntseng li hlaha liindastering tse fapaneng ho netefatsa hore bareki ba rona ba itokisetsa litlhoko tse tsoelang pele tsa bareki ba bona.

Iteanye le rona:
Tsebo ea 'Maraka oa Bokamoso
Yuniti ea Che: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Bakeng sa Lipotso tsa Thekiso: [imeile e sirelelitsoe]
Bakeng sa Lipotso tsa Media: [imeile e sirelelitsoe]
Webosaete: https://www.futuremarketinsights.com

Mohloli oa mohloli

Litaba Tse Amanang

Mabapi le mongoli

mohlophisi

Mohlophisi e moholo oa eTurboNew ke Linda Hohnholz. O lula ntlong e kholo ea eTN e Honolulu, Hawaii.

Leave a Comment

Arolelana ho...